State-of-the-art ultrasonography of hepatocellular carcinoma

European Journal of Radiology

Volumn 58, Issue 2, 2006, Pages 177-185

  Lee, Jae Young ^a   Choi, Byung Ihn ^a   Han, Joon Koo ^a   Lee, Jeong Min ^a   Kim, Se Hyung ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Hepatocellular carcinoma; Ultrasonography

Indexed keywords

DIAGNOSIS; DOPPLER EFFECT; HEALTH CARE; IMAGE PROCESSING; IMAGING TECHNIQUES; ULTRASONICS;

HEPATOCELLULAR CARCINOMA; ULTRASONOGRAPHY;

BIOLOGICAL ORGANS;

ARTICLE; CHEMOEMBOLIZATION; CONTRAST ENHANCEMENT; DOPPLER FLOWMETRY; ECHOGRAPHY; HUMAN; LIVER CELL CARCINOMA; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION;

CARCINOMA, HEPATOCELLULAR; HUMANS; IMAGING, THREE-DIMENSIONAL; LIVER; LIVER NEOPLASMS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 33646093712     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2005.11.038     Document Type: Article

References (40)

1. Mima S., Sekiya C., Kanagawa H., et al. Mass screening for hepatocellular carcinoma: experience in Hokkaido, Japan. J Gastroenterol Hepatol 9 4 (1994) 361-365
2. Nguyen M.H., and Keeffe E.B. Screening for hepatocellular carcinoma. J Clin Gastroenterol 35 5 Suppl 2 (2002) S86-S91
3. Choi B.I., Kim C.W., Han M.C., et al. Sonographic characteristics of small hepatocellular carcinoma. Gastrointest Radiol 14 3 (1989) 255-261
4. Sodhi K.S., Sidhu R., Gulati M., Saxena A., Suri S., and Chawla Y. Role of tissue harmonic imaging in focal hepatic lesions: comparison with conventional sonography. J Gastroenterol Hepatol 20 10 (2005) 1488-1493
5. Tranquart F., Grenier N., Eder V., and Pourcelot L. Clinical use of ultrasound tissue harmonic imaging. Ultrasound Med Biol 25 6 (1999) 889-894
6. Kim K.W., Choi B.I., Yoo S.Y., et al. Real-time compound ultrasonography: pictorial review of technology and the preliminary experience in clinical application of the abdomen. Abdom Imaging 29 4 (2004) 491-497
7. Entrekin R.R., Porter B.A., Sillesen H.H., Wong A.D., Cooperberg P.L., and Fix C.H. Real-time spatial compound imaging: application to breast, vascular, and musculoskeletal ultrasound. Semin Ultrasound CT MR 22 1 (2001) 50-64
8. Jespersen S.K., Wilhjelm J.E., and Sillesen H. In vitro spatial compound scanning for improved visualization of atherosclerosis. Ultrasound Med Biol 26 8 (2000) 1357-1362
9. Shapiro R.S., Simpson W.L., Rausch D.L., and Yeh H.C. Compound spatial sonography of the thyroid gland: evaluation of freedom from artifacts and of nodule conspicuity. Am J Roentgenol 177 5 (2001) 1195-1198
10. Meuwly J.Y., Thiran J.P., and Gudinchet F. Application of adaptive image processing technique to real-time spatial compound ultrasound imaging improves image quality. Invest Radiol 38 5 (2003) 257-262
11. Ohishi H., Hirai T., Yamada R., et al. Three-dimensional power Doppler sonography of tumor vascularity. J Ultrasound Med 17 10 (1998) 619-622
12. Xu H.X., Liu L., Lu M.D., Li H.P., Liu G.J., and Li J.P. Three-dimensional power Doppler imaging in depicting vascularity in hepatocellular carcinoma. J Ultrasound Med 22 11 (2003) 1147-1154
13. Fleischer A.C., Wojcicki W.E., Donnelly E.F., et al. Quantified color Doppler sonography of tumor vascularity in an animal model. J Ultrasound Med 18 8 (1999) 547-551
14. Carson P.L., Fowlkes J.B., Roubidoux M.A., et al. 3D color Doppler image quantification of breast masses. Ultrasound Med Biol 24 7 (1998) 945-952
15. Kupesic S., Bekavac I., Bjelos D., and Kurjak A. Assessment of endometrial receptivity by transvaginal color Doppler and three-dimensional power Doppler ultrasonography in patients undergoing in vitro fertilization procedures. J Ultrasound Med 20 2 (2001) 125-134
16. Fleischer A.C. Sonographic depiction of tumor vascularity and flow: from in vivo models to clinical applications. J Ultrasound Med 19 1 (2000) 55-61
17. Kim A.Y., Choi B.I., Kim T.K., et al. Hepatocellular carcinoma: power Doppler US with a contrast agent-preliminary results. Radiology 209 1 (1998) 135-140
18. Choi B.I., Kim T.K., Han J.K., Kim A.Y., Seong C.K., and Park S.J. Vascularity of hepatocellular carcinoma: assessment with contrast-enhanced second-harmonic versus conventional power Doppler US. Radiology 214 2 (2000) 381-386
19. Kim T.K., Choi B.I., Han J.K., Hong H.S., Park S.H., and Moon S.G. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 216 2 (2000) 411-417
20. Lee J.Y., Choi B.I., Han J.K., Kim A.Y., Shin S.H., and Moon S.G. Improved sonographic imaging of hepatic hemangioma with contrast-enhanced coded harmonic angiography: comparison with MR imaging. Ultrasound Med Biol 28 3 (2002) 287-295
21. Wen Y.L., Kudo M., Zheng R.Q., et al. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. Am J Roentgenol 182 4 (2004) 1019-1026
22. Choi B.I., Kim A.Y., Lee J.Y., et al. Hepatocellular carcinoma: contrast enhancement with Levovist. J Ultrasound Med 21 1 (2002) 77-84
23. Youk J.H., Lee J.M., and Kim C.S. Therapeutic response evaluation of malignant hepatic masses treated by interventional procedures with contrast-enhanced agent detection imaging. J Ultrasound Med 22 9 (2003) 911-920
24. Freeny P.C., and Marks W.M. Patterns of contrast enhancement of benign and malignant hepatic neoplasms during bolus dynamic and delayed CT. Radiology 160 3 (1986) 613-618
25. Honda H., Matsuura Y., Onitsuka H., et al. Differential diagnosis of hepatic tumors (hepatoma, hemangioma, and metastasis) with CT: value of two-phase incremental imaging. Am J Roentgenol 159 4 (1992) 735-740
26. Quillin S.P., Atilla S., Brown J.J., Borrello J.A., Yu C.Y., and Pilgram T.K. Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions. Magn Reson Imaging 15 3 (1997) 275-285
27. Quaia E., Calliada F., Bertolotto M., et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 232 2 (2004) 420-430
28. Harvey C.J., Lim A.K., Blomley M.J., Taylor-Robinson S.D., Gedroyc W.M., and Cosgrove D.O. Detection of an occult hepatocellular carcinoma using ultrasound with liver-specific microbubbles. Eur Radiol 12 Suppl 3 (2002) S70-S73
29. Tanaka S., Ioka T., Oshikawa O., Hamada Y., and Yoshioka F. Dynamic sonography of hepatic tumors. Am J Roentgenol 177 4 (2001) 799-805
30. Dill-Macky M.J., Burns P.N., Khalili K., and Wilson S.R. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US. Radiology 222 1 (2002) 95-102
31. Sumi S., Yamashita Y., Mitsuzaki K., et al. Power Doppler sonography assessment of tumor recurrence after chemoembolization therapy for hepatocellular carcinoma. Am J Roentgenol 172 1 (1999) 67-71
32. Hosoki T., Yosioka Y., Matsubara T., et al. Power Doppler sonography of hepatocellular carcinoma treated by transcatheter arterial chemoembolization. Assessment of the therapeutic effect. Acta Radiol 40 6 (1999) 639-643
33. Cioni D., Lencioni R., and Bartolozzi C. Percutaneous ablation of liver malignancies: imaging evaluation of treatment response. Eur J Ultrasound 13 2 (2001) 73-93
34. Ding H., Kudo M., Onda H., et al. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology 221 3 (2001) 721-730
35. Solbiati L., Ierace T., Tonolini M., and Cova L. Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol 51 Suppl (2004) S19-S23
36. Kubota K., Hisa N., Nishikawa T., et al. Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI. Abdom Imaging 26 2 (2001) 184-190
37. De Santis M., Alborino S., Tartoni P.L., et al. Effects of lipiodol retention on MRI signal intensity from hepatocellular carcinoma and surrounding liver treated by chemoembolization. Eur Radiol 7 1 (1997) 10-16
38. Kuszyk B.S., Boitnott J.K., Choti M.A., et al. Local tumor recurrence following hepatic cryoablation: radiologic-histopathologic correlation in a rabbit model. Radiology 217 2 (2000) 477-486
39. Morimoto M., Shirato K., Sugimori K., et al. Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Am J Roentgenol 181 1 (2003) 65-69
40. Choi D., Lim H.K., Kim S.H., et al. Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radio frequency ablation: comparison of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent. J Ultrasound Med 21 4 (2002) 391-401